Mouse CEA(Carcinoembryonic Antigen) ELISA Kit
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
RDR-CEA-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 693.6 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 482.4 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 663.6 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Mu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 4138.42 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Mu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 445.99 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Mu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 585.7 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Mu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2275.63 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
4-SEA150Mu |
Cloud-Clone |
-
EUR 4198.80
-
EUR 2216.40
-
EUR 586.80
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
RDR-CEA-Mu-48T |
Reddot Biotech |
48T |
EUR 355.22 |
|
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
RDR-CEA-Mu-96T |
Reddot Biotech |
96T |
EUR 507.47 |
|
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Mu-48T |
Reddot Biotech |
48T |
EUR 338.3 |
|
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Mu-96T |
Reddot Biotech |
96T |
EUR 483.3 |
|
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
ELISA kit for Mouse CEA (Carcinoembryonic Antigen) |
E-EL-M0232 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Mouse CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Mouse CEA (Carcinoembryonic Antigen) |
ELK1130 |
ELK Biotech |
1 plate of 96 wells |
EUR 446.4 |
|
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Human CEA(Carcinoembryonic Antigen) ELISA Kit |
EH0090 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml |
Rat Carcinoembryonic Antigen ELISA Kit (CEA) |
RK03562 |
Abclonal |
96 Tests |
EUR 625.2 |
Human Carcinoembryonic Antigen ELISA Kit (CEA) |
RK01085 |
Abclonal |
96 Tests |
EUR 625.2 |
Mouse Carcinoembryonic Antigen (CEA) CLIA Kit |
20-abx491146 |
Abbexa |
-
EUR 8853.60
-
EUR 4719.60
-
EUR 1093.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
abx256792-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
20-abx155329 |
Abbexa |
-
EUR 7087.20
-
EUR 3780.00
-
EUR 886.80
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Pig Carcinoembryonic Antigen (CEA) ELISA Kit |
abx361295-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Carcinoembryonic Antigen (CEA) (Rat) ELISA Kit |
E4742-100 |
Biovision |
each |
EUR 836.4 |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Ra-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 4358.33 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Ra-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 464.1 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Ra-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 611.57 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Ra-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2392.06 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
4-SEA150Ra |
Cloud-Clone |
-
EUR 4418.40
-
EUR 2332.80
-
EUR 612.00
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Carcinoembryonic Antigen (CEA) |
MO47049 |
Neuromics |
0.5 ml |
EUR 418.8 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
20-abx151022 |
Abbexa |
-
EUR 6373.20
-
EUR 3404.40
-
EUR 801.60
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
abx250227-96tests |
Abbexa |
96 tests |
EUR 764.4 |
|
Sheep Carcinoembryonic Antigen (CEA) ELISA Kit |
abx364185-96tests |
Abbexa |
96 tests |
EUR 1111.2 |
|
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
DLR-CEA-Hu-48T |
DL Develop |
48T |
EUR 439.2 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Carcinoembryonic Antigen (CEA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
DLR-CEA-Hu-96T |
DL Develop |
96T |
EUR 558 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Carcinoembryonic Antigen (CEA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human carcinoembryonic antigen, CEA ELISA Kit |
CSB-E04767h-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human carcinoembryonic antigen, CEA ELISA Kit |
1-CSB-E04767h |
Cusabio |
-
EUR 667.20
-
EUR 4634.40
-
EUR 2472.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Carcinoembryonic Antigen (CEA) (human) ELISA Kit |
K4805-100 |
Biovision |
100 assays |
EUR 970.8 |
|
Description: Sensitive, Colorimetric Assay |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
LF-EK60048 |
Abfrontier |
1×96T |
EUR 814.8 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
PRB-5059 |
Cell Biolabs |
96 assays |
EUR 686.4 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
PRB-5059-5 |
Cell Biolabs |
5 x 96 assays |
EUR 2739.6 |
Carcinoembryonic Antigen (CEA) (Human) ELISA Kit |
E4740-100 |
Biovision |
each |
EUR 966 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RDR-CEA-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 438 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RDR-CEA-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 600 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 420 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 574.8 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 3470.83 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 391.01 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 507.16 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 1922.21 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
4-SEA150Hu |
Cloud-Clone |
-
EUR 3531.60
-
EUR 1862.40
-
EUR 507.60
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Carcinoembryonic Antigen (CEA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RDR-CEA-Hu-48T |
Reddot Biotech |
48T |
EUR 303.24 |
|
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RDR-CEA-Hu-96T |
Reddot Biotech |
96T |
EUR 433.13 |
|
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Hu-48T |
Reddot Biotech |
48T |
EUR 288.8 |
|
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Hu-96T |
Reddot Biotech |
96T |
EUR 412.5 |
|
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
ELISA kit for Rat CEA (Carcinoembryonic Antigen) |
E-EL-R0150 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Rat CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Rat CEA (Carcinoembryonic Antigen) |
ELK1297 |
ELK Biotech |
1 plate of 96 wells |
EUR 446.4 |
|
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Rabbit Carcinoembryonic Antigen (CEA) ELISA Kit |
abx362811-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Monkey Carcinoembryonic Antigen (CEA) ELISA Kit |
abx359529-96tests |
Abbexa |
96 tests |
EUR 990 |
|
CEA ELISA Kit| Rat Carcinoembryonic Antigen ELISA Kit |
EF017615 |
Lifescience Market |
96 Tests |
EUR 826.8 |
Mouse Carcinoembryonic Antigen (CEA) Protein |
20-abx065720 |
Abbexa |
-
EUR 828.00
-
EUR 343.20
-
EUR 2532.00
-
EUR 978.00
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Carcinoembryonic Antigen (CEA) Protein |
20-abx065722 |
Abbexa |
-
EUR 811.20
-
EUR 343.20
-
EUR 2498.40
-
EUR 961.20
-
EUR 577.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Chicken Carcinoembryonic Antigen (CEA) ELISA Kit |
abx356418-96tests |
Abbexa |
96 tests |
EUR 990 |
|
ELISA kit for Human CEA (Carcinoembryonic Antigen) |
E-EL-H0643 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Human CEA (Carcinoembryonic Antigen) |
ELK1196 |
ELK Biotech |
1 plate of 96 wells |
EUR 446.4 |
|
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA |
LF-EK0161 |
Abfrontier |
1×96T |
EUR 723.6 |
ELISA kit for Human carcinoembryonic antigen,CEA |
EK0179 |
SAB |
96 tests |
EUR 794.4 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human carcinoembryonic antigen,CEA in samples from serum, plasma, tissue homogenates and other biological fluids. |
Human carcinoembryonic antigen (CEA) antigen |
CEA15-N-100 |
Alpha Diagnostics |
100 ug |
EUR 270 |
Active Carcinoembryonic Antigen (CEA) |
4-APA150Hu04 |
Cloud-Clone |
-
EUR 778.02
-
EUR 331.20
-
EUR 2587.58
-
EUR 942.53
-
EUR 1765.06
-
EUR 596.40
-
EUR 6288.96
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
Human Carcinoembryonic Antigen (CEA) OneStep ELISA Kit |
EK7031 |
BosterBio |
96wells/kit, with removable strips. |
EUR 573.6 |
Human Carcinoembryonic Antigen (CEA) ELISA (4X96T) |
LF-EK0162 |
Abfrontier |
4×96T |
EUR 2454 |
Carcinoembryonic Antigen (CEA) Antibody |
20-abx270133 |
Abbexa |
-
EUR 560.40
-
EUR 644.40
-
EUR 326.40
-
EUR 978.00
-
EUR 427.20
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx270165 |
Abbexa |
-
EUR 560.40
-
EUR 644.40
-
EUR 326.40
-
EUR 978.00
-
EUR 427.20
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx270190 |
Abbexa |
-
EUR 560.40
-
EUR 644.40
-
EUR 326.40
-
EUR 978.00
-
EUR 427.20
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody |
abx231576-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx175703 |
Abbexa |
-
EUR 410.40
-
EUR 159.60
-
EUR 1144.80
-
EUR 577.20
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx171571 |
Abbexa |
|
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx171572 |
Abbexa |
|
|
|
Carcinoembryonic Antigen (CEA) Antibody |
abx120020-1mg |
Abbexa |
1 mg |
EUR 944.4 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx022526-01ml |
Abbexa |
0.1 ml |
EUR 1328.4 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020536-1mg |
Abbexa |
1 mg |
EUR 944.4 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020540-1mg |
Abbexa |
1 mg |
EUR 944.4 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020541-1mg |
Abbexa |
1 mg |
EUR 910.8 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020542-1mg |
Abbexa |
1 mg |
EUR 828 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020543-1mg |
Abbexa |
1 mg |
EUR 886.8 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020544-1mg |
Abbexa |
1 mg |
EUR 828 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020545-1mg |
Abbexa |
1 mg |
EUR 828 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020546-1mg |
Abbexa |
1 mg |
EUR 828 |
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx102321 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 944.40
-
EUR 493.20
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx102322 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 944.40
-
EUR 493.20
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx102323 |
Abbexa |
-
EUR 393.60
-
EUR 159.60
-
EUR 1095.60
-
EUR 560.40
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx102324 |
Abbexa |
-
EUR 393.60
-
EUR 159.60
-
EUR 1095.60
-
EUR 560.40
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx128498 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 944.40
-
EUR 493.20
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx128499 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 944.40
-
EUR 493.20
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
CEA Antibody / Carcinoembryonic Antigen |
RQ5159 |
NSJ Bioreagents |
100ul |
EUR 356.15 |
Description: This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. [RefSeq] |
CEA Antibody / Carcinoembryonic Antigen |
V3527-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3527-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3527SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3597-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3597-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3597IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3597SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3598-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3598-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3598IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3598SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3599-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3599-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3599IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3599SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3716-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3716-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3716IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3716SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V8890-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V8890-20UG |
NSJ Bioreagents |
20ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V8890SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9002-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9002-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9002IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9002SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9003-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9003-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9003IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9003SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9008-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9008-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9008IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9008SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9164-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9164-20UG |
NSJ Bioreagents |
20ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9164SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9318-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9318-20UG |
NSJ Bioreagents |
20ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9318SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V4046-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V4046-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V4046SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V7069-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
V7069-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
V7069IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
V7069SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
V2444-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2444-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2444IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2444SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
Mouse CEA(Carcinoembryonic Antigen) ELISA Kit